Alan Seth Krasner Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity

CRNX Quotes by TradingView

Alan Seth Krasner is Chief Medical Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 43,210 shares of CRNX, which is worth approximately $2.39 Million. The most recent transaction as insider was on Oct 17, 2023, when has been sold 7,000 shares (Common Stock) at a price of $30.0 per share, resulting in proceeds of $210,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.2K
0% 3M change
0% 12M change
Total Value Held $2.39 Million

Alan Seth Krasner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 17 2023
SELL
Open market or private sale
$210,000 $30.0 p/Share
7,000 Reduced 13.94%
43,210 Common Stock
Oct 17 2023
BUY
Exercise of conversion of derivative security
$84,070 $12.01 p/Share
7,000 Added 12.24%
50,210 Common Stock
Mar 16 2023
SELL
Payment of exercise price or tax liability
$28,881 $17.12 p/Share
1,687 Reduced 3.84%
42,301 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
19,500 Added 30.71%
43,988 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
14,250 Added 38.71%
22,561 Common Stock
Jan 19 2022
SELL
Open market or private sale
$142,107 $21.21 p/Share
6,700 Reduced 44.63%
8,311 Common Stock
Jan 19 2022
BUY
Exercise of conversion of derivative security
$80,467 $12.01 p/Share
6,700 Added 30.86%
15,011 Common Stock
Jul 20 2018
BUY
Open market or private purchase
$34,000 $17.0 p/Share
2,000 Added 50.0%
2,000 Common Stock
ASK

Alan Seth Krasner

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on CRNX

Follow Crinetics Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRNX shares.

Notify only if

Insider Trading

Get notified when an Crinetics Pharmaceuticals, Inc. insider buys or sells CRNX shares.

Notify only if

News

Receive news related to Crinetics Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRNX